Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoichi Taya

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
The Journal of Biological Chemistry|April 2, 2011
Cancer susceptibility polymorphism of p53 at codon 72 affects phosphorylation and degradation of p53 proteinChikako Ozeki, Yuichiro Sawai, Tatsuhiro Shibata, et al.
Neuron|July 6, 2005
p53 mediates cellular dysfunction and behavioral abnormalities in Huntington's diseaseByoung-Il Bae, Hong Xu, Shuichi Igarashi, et al.
Scientific Reports|January 13, 2016
IER5 generates a novel hypo-phosphorylated active form of HSF1 and contributes to tumorigenesisYoshinori Asano, Tatsuya Kawase, Atsushi Okabe, et al.
Molecular and Cellular Biology|October 18, 2005
DNA damage-induced phosphorylation of MdmX at serine 367 activates p53 by targeting MdmX for Mdm2-dependent degradationKoji Okamoto, Kenji Kashima, Yaron Pereg, et al.
Cancer Science|March 22, 2016
Novel p53 target gene FUCA1 encodes a fucosidase and regulates growth and survival of cancer cellsIssei Ezawa, Yuichiro Sawai, Tatsuya Kawase, et al.
Blood|September 13, 2003
Identification and characterization of polymorphic variations of the ataxia telangiectasia mutated (ATM) gene in childhood Hodgkin diseaseMasatoshi Takagi, Rika Tsuchida, Kaoru Oguchi, et al.
Cell|July 17, 2007
CIP2A inhibits PP2A in human malignanciesMelissa R Junttila, Pietri Puustinen, Minna Niemelä, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 10, 2014
PHLDA3 is a novel tumor suppressor of pancreatic neuroendocrine tumorsRieko Ohki, Kozue Saito, Yu Chen, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
The Journal of Biological Chemistry|April 2, 2011
Cancer susceptibility polymorphism of p53 at codon 72 affects phosphorylation and degradation of p53 proteinChikako Ozeki, Yuichiro Sawai, Tatsuhiro Shibata, et al.
Neuron|July 6, 2005
p53 mediates cellular dysfunction and behavioral abnormalities in Huntington's diseaseByoung-Il Bae, Hong Xu, Shuichi Igarashi, et al.
Scientific Reports|January 13, 2016
IER5 generates a novel hypo-phosphorylated active form of HSF1 and contributes to tumorigenesisYoshinori Asano, Tatsuya Kawase, Atsushi Okabe, et al.
Molecular and Cellular Biology|October 18, 2005
DNA damage-induced phosphorylation of MdmX at serine 367 activates p53 by targeting MdmX for Mdm2-dependent degradationKoji Okamoto, Kenji Kashima, Yaron Pereg, et al.
Cancer Science|March 22, 2016
Novel p53 target gene FUCA1 encodes a fucosidase and regulates growth and survival of cancer cellsIssei Ezawa, Yuichiro Sawai, Tatsuya Kawase, et al.
Blood|September 13, 2003
Identification and characterization of polymorphic variations of the ataxia telangiectasia mutated (ATM) gene in childhood Hodgkin diseaseMasatoshi Takagi, Rika Tsuchida, Kaoru Oguchi, et al.
Cell|July 17, 2007
CIP2A inhibits PP2A in human malignanciesMelissa R Junttila, Pietri Puustinen, Minna Niemelä, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 10, 2014
PHLDA3 is a novel tumor suppressor of pancreatic neuroendocrine tumorsRieko Ohki, Kozue Saito, Yu Chen, et al.
Pageof 5